Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Dr. Jaleel Miyan | The University of Manchester | United Kingdom

Dr. Jaleel Ahmad Miyan is a distinguished British neuroscientist and Senior Lecturer at the Faculty of Biology, Medicine & Health, Division of Neuroscience, University of Manchester, with a long-standing career dedicated to understanding cerebrospinal fluid (CSF) physiology and its role in neurological disorders. As President of the Society for Research into Hydrocephalus & Spina Bifida and a Fellow of both the Higher Education Academy and the Royal Society of Biology, he is recognized internationally for his expertise in cerebral folate metabolism and hydrocephalus research. His principal work focuses on fetal-onset and neonatal hydrocephalus, aiming to develop a non-invasive, non-surgical treatment to address global disparities in care. Miyan has supervised numerous PhD and Masters students, postdoctoral researchers, and technicians, fostering research excellence. He has published over 120 peer-reviewed research papers and reviews, with an h-index of 34, and his work has garnered substantial citations, reflecting his impact in neuroscience. He has served on editorial boards, contributed to major research projects, and secured significant funding for studies on folate metabolism in neurological conditions. Miyan’s scholarship is accessible through his ResearchGate, Orcid, and Google Scholar profiles, showcasing his profound contributions to advancing neuroscience and improving treatments for devastating neurological conditions.

Profiles : Google Scholar | Orcid | Research Gate

Featured Publications

Downing, J. E. G., & Miyan, J. A. (2000). Neural immunoregulation: Emerging roles for nerves in immune homeostasis and disease. Immunology Today, 21(6), 281–289.

Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014). Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Frontiers in Neuroscience, 8, 23.

Miyan, J. A., Nabiyouni, M., & Zendah, M. (2003). Development of the brain: A vital role for cerebrospinal fluid. Canadian Journal of Physiology and Pharmacology, 81(4), 317–328.

Gazi, E., Dwyer, J., Lockyer, N. P., Miyan, J., Gardner, P., Hart, C., & Brown, M., et al. (2005). Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy. Biopolymers: Original Research on Biomolecules, 77(1), 18–30.

Mashayekhi, F., Draper, C. E., Bannister, C. M., Pourghasem, M., & Miyan, J. A., et al. (2002). Deficient cortical development in the hydrocephalic Texas (H‐Tx) rat: A role for CSF. Brain, 125(8), 1859–1874.

Owen‐Lynch, P. J., Draper, C. E., Mashayekhi, F., Bannister, C. M., & Miyan, J. A. (2003). Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain, 126(3), 623–631.

Thais Reis Lage Nunes | Stroke | Best Researcher Award

Published on by Neuroscientists

Ms. Thais Reis Lage Nunes | Stroke | Best Researcher Award

Universidade Federal de Minas Gerais | Brazil

Thais Aparecida Reis Lage is a Brazilian physician and neurologist with a background in clinical cardiology and stroke in Chagas disease, and expertise in internist medicine. She earned her medical degree from the Universidade Federal de Minas Gerais and completed specialization in neurology, followed by a master’s in Infectious and Tropical Medicine where she studied factors associated with ischemic stroke in patients with Chagas cardiomyopathy. Her professional experience includes roles as internist, emergency clinician, and neurologist at various institutions in Belo Horizonte, and she is also active in hospital work via public service and part-time positions. She has contributed to scientific literature, including a paper on a murine model studying brain, behavior, and immunity during hepatic encephalopathy. According to available bibliometric sources, she has 8 documents and 1 citation, with an h-index of 5. She is fluent in Portuguese and English, with functional proficiency in Spanish, and is involved in medical and academic activities including teaching, research, and hospital practice. She lives in Belo Horizonte and conducts her professional work primarily tied to Universidade Federal de Minas Gerais and associated hospitals.

Profiles: Scopus

Featured Publications

“Predictors of ischemic stroke in Chagas disease: Insights into mechanisms beyond cardiomyopathy severity”

Wang Yanqiang | Stroke | Best Researcher Award

Published on by Neuroscientists

Prof. Wang Yanqiang | Stroke | Best Researcher Award

Prof. Wang Yanqiang,  Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China.

Dr. Yanqiang Wang is a distinguished neurologist and researcher specializing in ischemic brain injury, Parkinson’s disease, and cerebrovascular disorders. With an extensive academic background and international research experience, he has significantly contributed to the understanding and treatment of neurological diseases. Currently serving at the Affiliated Hospital of Weifang Medical University, his work continues to influence the global medical community.

 

Profile

Orcid

 

🎓 Early Academic Pursuits: A Strong Foundation in Neurology

Dr. Wang embarked on his academic journey at Xu Zhou Medical University, where he earned a Master’s degree in Neurology (2003-2006). His early research delved into the pathogenesis of Parkinson’s disease, igniting a passion for neurodegenerative disorders. Determined to further his expertise, he pursued a Ph.D. at Sun Yat-sen University (2012-2015), where he conducted groundbreaking research on ischemic stroke and neuromyelitis optica spectrum disorders. His academic endeavors laid the foundation for his illustrious career in neurology.

🏥 Professional Endeavors: Bridging Clinical Practice and Research

Dr. Wang’s medical career commenced at the Affiliated Hospital of Weifang Medical University, where he served as a resident and attending doctor in the Department of Immunology and Rheumatology (2006-2012). He later transitioned to neurology, assuming key roles at Shandong Second Medical University, where he currently serves as a director. His expertise in cerebrovascular diseases, particularly ischemic stroke, has led to significant advancements in patient care and treatment methodologies. In 2020, he expanded his horizons internationally as Vice-Director in the Department of Neurology at the University of Washington, USA, where he collaborated with leading researchers in cerebrovascular disease.

🎡 Contributions and Research Focus: Advancing Neurological Science

Throughout his career, Dr. Wang has remained committed to unraveling the complexities of neurological disorders. His research primarily focuses on the pathogenesis and neuroprotection of ischemic brain injury and Parkinson’s disease. His postdoctoral work at Xuzhou Medical University (2016-2019) further solidified his contributions to stroke research, offering new insights into treatment strategies. His clinical studies on neuromyelitis optica spectrum disorders have expanded the scientific community’s understanding of autoimmune neurological conditions.

🏆 Accolades and Recognition: Acknowledged for Excellence

Dr. Wang’s dedication to neurology has earned him numerous accolades, both nationally and internationally. His research publications in high-impact journals have been widely cited, influencing contemporary neurological studies. His leadership roles in various medical institutions and his tenure at the University of Washington further attest to his global recognition in the field. His contributions to stroke and neurodegenerative disease research have been acknowledged through invitations to prestigious medical conferences and collaborative research initiatives.

👁 Impact and Influence: Shaping the Future of Neurology

As a clinician, researcher, and mentor, Dr. Wang has had a profound impact on the medical community. His pioneering studies have improved diagnostic and therapeutic approaches for cerebrovascular diseases. By integrating research with clinical practice, he has enhanced patient outcomes and influenced future neurological research directions. His mentorship of young medical professionals and researchers ensures the continued advancement of neurology as a field.

🌱 Legacy and Future Contributions: Paving the Way for Innovations

Dr. Wang’s legacy lies in his relentless pursuit of excellence in neurology. His ongoing research on ischemic stroke and Parkinson’s disease continues to shape the future of neurological science. With a vision for innovation, he aims to develop novel therapeutic interventions that can transform the treatment landscape for cerebrovascular and neurodegenerative disorders. His contributions will undoubtedly leave an enduring mark on the field, inspiring future generations of neurologists and researchers.

Publication

  • Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury
    Authors: Yanghang Yang, Yulei Xia, Yue Ma, Mingtong Gao, Shuai Hou, Shanshan Xu, Yanqiang Wang
    Year: 2025

 

  • Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A Literature Review
    Authors: Weihua Wang, Dunlin Lu, Youkui Shi, Yanqiang Wang
    Year: 2024

 

  • Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis
    Authors: Xiaopan Liu, Ning Wu, Jian Li, Meng Pang, Yaozhen Wang, Yuge Wang, Shuai Jia, Yanqiang Wang
    Year: 2024

 

  • 1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling
    Authors: Ting Song, Jian Li, Yulei Xia, Shuai Hou, Xiaojun Zhang, Yanqiang Wang
    Year: 2024

 

  • A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation
    Authors: Yingzhe Zhao, Shuai Jia, Jian Li, Jianhong Geng, Yanqiang Wang, Xiaomei Cui
    Year: 2024

 

  • A case report of drug-coated balloon dilation angioplasty in a patient with acute atherosclerotic basilar artery occlusion
    Authors: Xiaomei Cui, Yong-Deng Li, Shuai Jia, Yan-Qiang Wang
    Year: 2024

 

  • Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021
    Authors: Shuai Hou, Yifeng Zhang, Yulei Xia, Yong Liu, Xia Deng, Weihua Wang, Yanqiang Wang, Chunping Wang, Gang Wang
    Year: 2024

 

  • Genetic insights into the relationship between immune cell characteristics and ischemic stroke: A bidirectional Mendelian randomization study
    Authors: Xia Deng, Shuai Hou, Yanqiang Wang, Haiyan Yang, Chunping Wang
    Year: 2024

 

  • Assessing tobacco-related ischemic stroke in Pakistan (1990-2019): Insights from the Global Burden of Disease Study
    Authors: Shuai Hou, Pang M, Zhang Y, Xia Y, Wang Y, Wang G
    Year: 2024

 

  • First report of a p.Cys484Tyr Notch3 mutation in a CADASIL patient with acute bilateral multiple subcortical infarcts—case report and brief review
    Authors: Weili Liu, Jie Zhang, Jian Li, Shuai Jia, Yanqiang Wang, Jianhong Geng, Yaozhen Wang
    Year: 2024

 

💡 Conclusion

Dr. Yanqiang Wang’s career exemplifies dedication, innovation, and leadership in neurology. From his early academic endeavors to his global contributions, he has continuously pushed the boundaries of medical science. His work not only benefits current patients but also paves the way for future breakthroughs in neurological research. As he continues to explore new frontiers in neuroscience, his impact on the medical community remains unparalleled.